CVMP: Working parties and other groups

The Committee for Veterinary Medicinal Products (CVMP) establishes a number of working parties at the beginning of each three-year mandate. These working parties have expertise in a particular scientific field, and are composed of members selected from the list of European experts maintained by the Agency.

Updated on 6 October 2025 to reflect the current structure of working parties and other groups under CVMP

The CVMP consults its working parties on scientific issues relating to their particular field of expertise, and delegates certain tasks to them associated with the scientific evaluation of marketing authorisation applications or drafting and revision of scientific guidance documents.

Working parties and groups

The current CVMP working parties are:

• 3Rs Working Party
• Antimicrobials Working Party
• Dosage Review and Adjustment of Established Veterinary Antibiotics temporary Working Party
• Efficacy Working Party
• Environmental Risk Assessment Working Party
• Immunologicals Working Party
• Quality Working Party
• Novel Therapies and Technologies Working Party
• European Sales and Use of Antimicrobials for Veterinary Medicine Working Group
• Pharmacovigilance Working Party
• Safety Working Party
• Scientific Advice Working Party: veterinary medicines

The working parties are supported by the following scientific groups:

• Pilot Signal Management Expert Group

Other CVMP-associated groups

The CVMP also establishes other groups to provide expertise. The CVMP consults these groups and delegates to them certain tasks associated with marketing authorisations, applications, and the drafting and revision of guidance documents.

The current CVMP-associated groups are:

• Environmental Risk Assessment European Specialised Expert Community (ERA ESEC)
• Working Group on Quality Review of Documents
• Active Substance Master File Working Group
• Antimicrobial Advice Ad Hoc Expert Group (AMEG)

The CHMP is further supported by the work of the Good Manufacturing Practice (GMP), Good Clinical Practice (GCP), Pharmacovigilance (PhV) and Good Laboratory Practice (GLP) Inspectors Working Groups (IWG). Information on their role is available under Compliance.